Efficacy of Thoracoscopic Bronchial Sleeve Plastic Lobectomy in the Treatment of Central Small Cell Lung Cancer
Objective To investigate the efficacy of thoracoscopic bronchial sleeve plastic lobectomy in the treatment of central small cell lung cancer.Methods A total of 82 patients with central small cell lung cancer who received treatment in the First Affiliated Hospital of Zhengzhou University from January 2019 to May 2020 were selected as the study objects,and were divided into the observation group(receiving thoracoscopic bronchoplasty sleeve pulmonary lobotomy)and the control group(receiving traditional surgical treatment),with 41 cases in each group.Perioperative indexes,complication rate,survival rate,progression-free survival time and recurrence rate were compared between the two groups.Visual analogue scale(VAS)and Karnofsky functional status score(KPS)were analyzed.Results The intraoperative blood loss(231.49±23.56)mL and thoracic drainage flow(902.20±102.39)mL in the observation group were less than those in the control group[(302.17± 30.41)mL and(1 145.32±172.41)mL].The postoperative drainage time(6.15±1.41)days and hospitalization time(11.41±2.49)days were shorter than those in the control group[(7.10±1.93)days and(13.56±3.24)days](P＜0.05).The postoperative complication rate,recurrence rate and VAS score in the observation group were lower than those in the control group,and KPS score was higher than those in the control group(P＜0.05).The progression-free survival time of observation group was longer than that of control group(P＜0.05).Conclusion Thoracoscopic sleeve bronchoplastic pulmonary lobectomy is beneficial to reduce the incidence of complications and prolong progression-free survival.
万方数据
维普
